CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
CASH FLOW FROM OPERATING ACTIVITIES
Net loss	$ (2,500,176)	$ (1,773,654)
Adjustments to reconcile net loss to net cash used in operating activities
Amortization	80,312	80,312
Depreciation	20,568	0
Stock-based compensation and warrants	184,562	209,071
(Increase) decrease in assets
Prepaid drug product for testing	(541,177)	(89,981)
Other current assets	(153,121)	(107,446)
Increase (decrease) in liabilities
Accounts payable and accrued expenses	130,233	38,621
Net cash used in operating activities	(2,778,799)	(1,643,077)
CASH FLOW FROM FINANCING ACTIVITIES
Net proceeds from sale of common stock	0	13,812,373
Net cash from financing activities	0	13,812,373
NET INCREASE (DECREASE) IN CASH	(2,778,799)	12,169,296
Cash, beginning of period	13,858,798	3,551,832
Cash, end of period	$ 11,079,999	$ 15,721,128